Codexis Inc (CDXS)
3.56
-0.36
(-9.18%)
USD |
NASDAQ |
May 06, 16:00
3.57
+0.01
(+0.28%)
After-Hours: 20:00
Codexis Free Cash Flow (Quarterly): -8.919M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -8.919M |
December 31, 2023 | -10.66M |
September 30, 2023 | -16.98M |
June 30, 2023 | -17.67M |
March 31, 2023 | -11.75M |
December 31, 2022 | 4.95M |
September 30, 2022 | 18.42M |
June 30, 2022 | -4.122M |
March 31, 2022 | -16.28M |
December 31, 2021 | -4.82M |
September 30, 2021 | -4.196M |
June 30, 2021 | -10.09M |
March 31, 2021 | -8.99M |
December 31, 2020 | -2.98M |
September 30, 2020 | -4.244M |
June 30, 2020 | -10.80M |
March 31, 2020 | -2.186M |
December 31, 2019 | -4.076M |
September 30, 2019 | -3.047M |
June 30, 2019 | -5.871M |
March 31, 2019 | -3.296M |
December 31, 2018 | -1.414M |
September 30, 2018 | -1.835M |
June 30, 2018 | -9.412M |
March 31, 2018 | -4.201M |
Date | Value |
---|---|
December 31, 2017 | 7.384M |
September 30, 2017 | -4.913M |
June 30, 2017 | -8.408M |
March 31, 2017 | -3.803M |
December 31, 2016 | 5.062M |
September 30, 2016 | -7.523M |
June 30, 2016 | -0.241M |
March 31, 2016 | -0.046M |
December 31, 2015 | 6.245M |
September 30, 2015 | 0.326M |
June 30, 2015 | -4.303M |
March 31, 2015 | -3.90M |
December 31, 2014 | 4.939M |
September 30, 2014 | 1.53M |
June 30, 2014 | -4.024M |
March 31, 2014 | -2.426M |
December 31, 2013 | -4.633M |
September 30, 2013 | -8.339M |
June 30, 2013 | -7.666M |
March 31, 2013 | -3.535M |
December 31, 2012 | -5.038M |
September 30, 2012 | -3.944M |
June 30, 2012 | -4.329M |
March 31, 2012 | -1.514M |
December 31, 2011 | -5.819M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-17.67M
Minimum
Jun 2023
18.42M
Maximum
Sep 2022
-6.215M
Average
-5.346M
Median
Free Cash Flow (Quarterly) Benchmarks
Avidity Biosciences Inc | 15.64M |
Taysha Gene Therapies Inc | -16.13M |
Janux Therapeutics Inc | -10.42M |
Tango Therapeutics Inc | -27.69M |
2seventy bio Inc | -64.67M |